

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of translational fidelity (GO:0006450) | 9.50738251 |
| 2 | modulation by symbiont of host cellular process (GO:0044068) | 9.46671603 |
| 3 | negative regulation of viral entry into host cell (GO:0046597) | 7.70420767 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 7.44378368 |
| 5 | negative regulation of viral release from host cell (GO:1902187) | 6.56169131 |
| 6 | fatty acid elongation (GO:0030497) | 6.46853219 |
| 7 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 6.22090425 |
| 8 | creatine metabolic process (GO:0006600) | 5.98504760 |
| 9 | modulation by virus of host morphology or physiology (GO:0019048) | 5.84190639 |
| 10 | vesicle targeting (GO:0006903) | 5.72037895 |
| 11 | regulation of viral entry into host cell (GO:0046596) | 5.62492000 |
| 12 | regulation of translational elongation (GO:0006448) | 5.53819905 |
| 13 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 5.47661656 |
| 14 | axon ensheathment (GO:0008366) | 5.40082387 |
| 15 | ensheathment of neurons (GO:0007272) | 5.40082387 |
| 16 | myelination (GO:0042552) | 5.33517467 |
| 17 | myelin maintenance (GO:0043217) | 5.32100770 |
| 18 | beta-amyloid metabolic process (GO:0050435) | 5.28823703 |
| 19 | transcytosis (GO:0045056) | 5.05003894 |
| 20 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 5.01224996 |
| 21 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.00995596 |
| 22 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.97824415 |
| 23 | skin morphogenesis (GO:0043589) | 4.88802587 |
| 24 | regulation of sequestering of triglyceride (GO:0010889) | 4.85749578 |
| 25 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.82630071 |
| 26 | positive regulation of receptor recycling (GO:0001921) | 4.67889549 |
| 27 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.67581521 |
| 28 | negative regulation of protein localization to cell surface (GO:2000009) | 4.49950854 |
| 29 | regulation of lipoprotein metabolic process (GO:0050746) | 4.49688664 |
| 30 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 4.45078231 |
| 31 | regulation of viral release from host cell (GO:1902186) | 4.43451260 |
| 32 | thioester biosynthetic process (GO:0035384) | 4.41068404 |
| 33 | acyl-CoA biosynthetic process (GO:0071616) | 4.41068404 |
| 34 | cellular response to zinc ion (GO:0071294) | 4.36936272 |
| 35 | response to lipoprotein particle (GO:0055094) | 4.30320612 |
| 36 | import into cell (GO:0098657) | 4.15843074 |
| 37 | triglyceride biosynthetic process (GO:0019432) | 4.08880944 |
| 38 | triglyceride catabolic process (GO:0019433) | 4.06853606 |
| 39 | response to dietary excess (GO:0002021) | 4.06012971 |
| 40 | basic amino acid transport (GO:0015802) | 3.98855839 |
| 41 | response to methylmercury (GO:0051597) | 3.94942448 |
| 42 | low-density lipoprotein particle clearance (GO:0034383) | 3.93355369 |
| 43 | neutral lipid biosynthetic process (GO:0046460) | 3.89765131 |
| 44 | acylglycerol biosynthetic process (GO:0046463) | 3.89765131 |
| 45 | macrophage activation involved in immune response (GO:0002281) | 3.88197581 |
| 46 | cholesterol biosynthetic process (GO:0006695) | 3.81668676 |
| 47 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.79532927 |
| 48 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 3.75602483 |
| 49 | tight junction assembly (GO:0070830) | 3.68072315 |
| 50 | regulation of meiosis I (GO:0060631) | 3.65724873 |
| 51 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.63932499 |
| 52 | mitochondrion degradation (GO:0000422) | 3.62205319 |
| 53 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.59244721 |
| 54 | amyloid precursor protein metabolic process (GO:0042982) | 3.54205969 |
| 55 | oligodendrocyte differentiation (GO:0048709) | 3.53023157 |
| 56 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.51671759 |
| 57 | negative regulation of receptor activity (GO:2000272) | 3.51128027 |
| 58 | glycerolipid catabolic process (GO:0046503) | 3.48128132 |
| 59 | membrane raft organization (GO:0031579) | 3.46152551 |
| 60 | neutral lipid catabolic process (GO:0046461) | 3.45706751 |
| 61 | acylglycerol catabolic process (GO:0046464) | 3.45706751 |
| 62 | sterol biosynthetic process (GO:0016126) | 3.44680862 |
| 63 | membrane tubulation (GO:0097320) | 3.44422832 |
| 64 | cellular response to epinephrine stimulus (GO:0071872) | 3.44067234 |
| 65 | very long-chain fatty acid metabolic process (GO:0000038) | 3.43161362 |
| 66 | autophagic vacuole fusion (GO:0000046) | 3.42652214 |
| 67 | lipid particle organization (GO:0034389) | 3.40406221 |
| 68 | positive regulation of glomerulus development (GO:0090193) | 3.38204331 |
| 69 | cerebral cortex neuron differentiation (GO:0021895) | 3.37425938 |
| 70 | modification by symbiont of host morphology or physiology (GO:0044003) | 3.37037657 |
| 71 | brain morphogenesis (GO:0048854) | 3.35452133 |
| 72 | biotin metabolic process (GO:0006768) | 3.35068308 |
| 73 | establishment of mitochondrion localization (GO:0051654) | 3.34048467 |
| 74 | photoreceptor cell differentiation (GO:0046530) | 3.28697848 |
| 75 | eye photoreceptor cell differentiation (GO:0001754) | 3.28697848 |
| 76 | brown fat cell differentiation (GO:0050873) | 3.28668519 |
| 77 | amino acid salvage (GO:0043102) | 3.27230703 |
| 78 | L-methionine salvage (GO:0071267) | 3.27230703 |
| 79 | L-methionine biosynthetic process (GO:0071265) | 3.27230703 |
| 80 | cellular response to pH (GO:0071467) | 3.26771339 |
| 81 | white fat cell differentiation (GO:0050872) | 3.24780556 |
| 82 | response to epinephrine (GO:0071871) | 3.24029808 |
| 83 | L-glutamate transport (GO:0015813) | 3.12025303 |
| 84 | branched-chain amino acid catabolic process (GO:0009083) | 3.09206693 |
| 85 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2 | 3.09151259 |
| 86 | respiratory electron transport chain (GO:0022904) | 3.08422951 |
| 87 | acidic amino acid transport (GO:0015800) | 3.08043512 |
| 88 | regulation of collateral sprouting (GO:0048670) | 3.06396473 |
| 89 | astrocyte development (GO:0014002) | 3.06206444 |
| 90 | acyl-CoA metabolic process (GO:0006637) | 3.04936967 |
| 91 | thioester metabolic process (GO:0035383) | 3.04936967 |
| 92 | negative regulation of acute inflammatory response (GO:0002674) | 3.04005395 |
| 93 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 3.03679563 |
| 94 | GPI anchor biosynthetic process (GO:0006506) | 3.02962534 |
| 95 | fatty acid beta-oxidation (GO:0006635) | 3.01904313 |
| 96 | negative regulation of neurotransmitter transport (GO:0051589) | 3.01798041 |
| 97 | electron transport chain (GO:0022900) | 3.00084068 |
| 98 | S-adenosylmethionine metabolic process (GO:0046500) | 2.99870867 |
| 99 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.94870251 |
| 100 | isoprenoid biosynthetic process (GO:0008299) | 2.94526366 |
| 101 | ethanol oxidation (GO:0006069) | 2.94322757 |
| 102 | cellular ketone body metabolic process (GO:0046950) | 2.93928238 |
| 103 | phosphatidic acid biosynthetic process (GO:0006654) | 2.93163205 |
| 104 | phosphatidic acid metabolic process (GO:0046473) | 2.93163205 |
| 105 | dorsal/ventral neural tube patterning (GO:0021904) | 2.91115328 |
| 106 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.89176100 |
| 107 | response to acidic pH (GO:0010447) | 2.88504515 |
| 108 | virion attachment to host cell (GO:0019062) | 2.88376841 |
| 109 | adhesion of symbiont to host cell (GO:0044650) | 2.88376841 |
| 110 | response to redox state (GO:0051775) | 2.87805814 |
| 111 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.86087817 |
| 112 | glycerophospholipid catabolic process (GO:0046475) | 2.85768365 |
| 113 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.84644151 |
| 114 | neutrophil activation (GO:0042119) | 2.83770625 |
| 115 | fatty acid catabolic process (GO:0009062) | 2.82911508 |
| 116 | regulation of receptor recycling (GO:0001919) | 2.82329844 |
| 117 | cerebellar Purkinje cell layer development (GO:0021680) | 2.82158218 |
| 118 | positive regulation of glial cell differentiation (GO:0045687) | 2.81793831 |
| 119 | GPI anchor metabolic process (GO:0006505) | 2.80619115 |
| 120 | amino-acid betaine metabolic process (GO:0006577) | 2.80525116 |
| 121 | branched-chain amino acid metabolic process (GO:0009081) | 2.79566962 |
| 122 | L-amino acid import (GO:0043092) | 2.76411988 |
| 123 | multicellular organism reproduction (GO:0032504) | 2.75882676 |
| 124 | regulation of somitogenesis (GO:0014807) | 2.75855521 |
| 125 | negative regulation of JUN kinase activity (GO:0043508) | 2.75154648 |
| 126 | tissue regeneration (GO:0042246) | 2.72158558 |
| 127 | substantia nigra development (GO:0021762) | 2.72155630 |
| 128 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.70863759 |
| 129 | valine metabolic process (GO:0006573) | 2.68434375 |
| 130 | amyloid precursor protein catabolic process (GO:0042987) | 2.68230380 |
| 131 | triglyceride metabolic process (GO:0006641) | 2.68147755 |
| 132 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.68053777 |
| 133 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.67128649 |
| 134 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.64636945 |
| 135 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.64581203 |
| 136 | regulation of metalloenzyme activity (GO:0048552) | 2.64291535 |
| 137 | positive regulation of meiosis (GO:0045836) | 2.63757251 |
| 138 | positive regulation of gliogenesis (GO:0014015) | 2.62909215 |
| 139 | acetyl-CoA metabolic process (GO:0006084) | 2.61739750 |
| 140 | ATP synthesis coupled proton transport (GO:0015986) | 2.61560248 |
| 141 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.61560248 |
| 142 | ketone body metabolic process (GO:1902224) | 2.61007461 |
| 143 | piRNA metabolic process (GO:0034587) | 2.60894992 |
| 144 | myelination in peripheral nervous system (GO:0022011) | 2.60640790 |
| 145 | peripheral nervous system axon ensheathment (GO:0032292) | 2.60640790 |
| 146 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.60114237 |
| 147 | asymmetric protein localization (GO:0008105) | 2.58881161 |
| 148 | axon development (GO:0061564) | 2.58731377 |
| 149 | fatty acid transmembrane transport (GO:1902001) | 2.58527354 |
| 150 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.58244705 |
| 151 | response to pH (GO:0009268) | 2.57250232 |
| 152 | carnitine shuttle (GO:0006853) | 2.56828365 |
| 153 | organelle membrane fusion (GO:0090174) | 2.56595866 |
| 154 | fatty acid homeostasis (GO:0055089) | 2.55347125 |
| 155 | fatty acid oxidation (GO:0019395) | 2.54264445 |
| 156 | positive regulation of meiotic cell cycle (GO:0051446) | 2.52804457 |
| 157 | fatty acid biosynthetic process (GO:0006633) | 2.51895165 |
| 158 | lipid oxidation (GO:0034440) | 2.51695051 |
| 159 | positive regulation of pseudopodium assembly (GO:0031274) | 2.51485160 |
| 160 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.51406949 |
| 161 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.48191218 |
| 162 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.46373124 |
| 163 | natural killer cell mediated immunity (GO:0002228) | 2.46373124 |
| 164 | positive regulation of receptor activity (GO:2000273) | 2.45501939 |
| 165 | granulocyte activation (GO:0036230) | 2.43618477 |
| 166 | seminiferous tubule development (GO:0072520) | 2.42653897 |
| 167 | acylglycerol homeostasis (GO:0055090) | 2.37561692 |
| 168 | triglyceride homeostasis (GO:0070328) | 2.37561692 |
| 169 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 2.37548747 |
| 170 | ribosomal small subunit assembly (GO:0000028) | 2.37143825 |
| 171 | positive regulation of tolerance induction (GO:0002645) | 2.36129945 |
| 172 | regulation of phospholipase A2 activity (GO:0032429) | 2.35955098 |
| 173 | positive regulation of translation (GO:0045727) | 2.35393128 |
| 174 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.33955089 |
| 175 | synaptic vesicle maturation (GO:0016188) | 2.31814609 |
| 176 | ethanol metabolic process (GO:0006067) | 2.31066986 |
| 177 | regulation of glomerulus development (GO:0090192) | 2.31054852 |
| 178 | ribosomal small subunit biogenesis (GO:0042274) | 2.29128038 |
| 179 | poly(A)+ mRNA export from nucleus (GO:0016973) | 12.2571919 |
| 180 | modulation by virus of host process (GO:0019054) | 11.5341850 |
| 181 | axon ensheathment in central nervous system (GO:0032291) | 10.2065043 |
| 182 | central nervous system myelination (GO:0022010) | 10.2065043 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.00951408 |
| 2 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.14917463 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.80904312 |
| 4 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.57173376 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.24716389 |
| 6 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.21463144 |
| 7 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.19951689 |
| 8 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.12008498 |
| 9 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.05940310 |
| 10 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.04417317 |
| 11 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.94581410 |
| 12 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.93422526 |
| 13 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.77488742 |
| 14 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.76933556 |
| 15 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.73663276 |
| 16 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.73197201 |
| 17 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.72674439 |
| 18 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.70131110 |
| 19 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.69260116 |
| 20 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.59326117 |
| 21 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.59013477 |
| 22 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.57438565 |
| 23 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.57114027 |
| 24 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.56561853 |
| 25 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.52863469 |
| 26 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.50594821 |
| 27 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.50554727 |
| 28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.47304734 |
| 29 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.46762354 |
| 30 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.46240303 |
| 31 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.45739326 |
| 32 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.45739326 |
| 33 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.41864024 |
| 34 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.40772426 |
| 35 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.40550280 |
| 36 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.37747813 |
| 37 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.36474331 |
| 38 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.36411428 |
| 39 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.35683507 |
| 40 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.34086589 |
| 41 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.33143914 |
| 42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.33058733 |
| 43 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.29756436 |
| 44 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.26188544 |
| 45 | * ERA_21632823_ChIP-Seq_H3396_Human | 1.26032742 |
| 46 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25201212 |
| 47 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.23181282 |
| 48 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.22367021 |
| 49 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.22367021 |
| 50 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.22076114 |
| 51 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.20545388 |
| 52 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.20545388 |
| 53 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.19992285 |
| 54 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.18686923 |
| 55 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.17114231 |
| 56 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.16499887 |
| 57 | GATA1_19941826_ChIP-Seq_K562_Human | 1.15132466 |
| 58 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.14860113 |
| 59 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.14502828 |
| 60 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.14202965 |
| 61 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.14161915 |
| 62 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.13174068 |
| 63 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.13002286 |
| 64 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.12583985 |
| 65 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.11920584 |
| 66 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.11526443 |
| 67 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.11080260 |
| 68 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10882661 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10434532 |
| 70 | KLF4_19829295_ChIP-Seq_ESCs_Human | 1.08897634 |
| 71 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.08660330 |
| 72 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.08158849 |
| 73 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.08087637 |
| 74 | SA1_27219007_Chip-Seq_Bcells_Human | 1.07532756 |
| 75 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.07406366 |
| 76 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.06300100 |
| 77 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.06158431 |
| 78 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.05787761 |
| 79 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.05478422 |
| 80 | SOX2_21211035_ChIP-Seq_LN229_Human | 1.04680345 |
| 81 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.03969242 |
| 82 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03949328 |
| 83 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.03592103 |
| 84 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.03537500 |
| 85 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.03177249 |
| 86 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.02434099 |
| 87 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.02236698 |
| 88 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.01542908 |
| 89 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.01455530 |
| 90 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.00696924 |
| 91 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.00150598 |
| 92 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.99363015 |
| 93 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.99077545 |
| 94 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.98764765 |
| 95 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.98706834 |
| 96 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98482510 |
| 97 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.97693956 |
| 98 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.97146939 |
| 99 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.96721730 |
| 100 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.96539562 |
| 101 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.95977517 |
| 102 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94949945 |
| 103 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.93826626 |
| 104 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.93444269 |
| 105 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92628747 |
| 106 | * HOXB7_26014856_ChIP-Seq_BT474_Human | 0.92472931 |
| 107 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.92463296 |
| 108 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91974070 |
| 109 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91704642 |
| 110 | P68_20966046_ChIP-Seq_HELA_Human | 0.91570978 |
| 111 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.91277009 |
| 112 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.90981608 |
| 113 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90758641 |
| 114 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90693042 |
| 115 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.90514052 |
| 116 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90105218 |
| 117 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.90095392 |
| 118 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89735745 |
| 119 | * CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.89675621 |
| 120 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.88296091 |
| 121 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88204898 |
| 122 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88184896 |
| 123 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.87146676 |
| 124 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.86829556 |
| 125 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.86829556 |
| 126 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.86785975 |
| 127 | CJUN_26792858_Chip-Seq_BT549_Human | 0.86600567 |
| 128 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.86537705 |
| 129 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.86533441 |
| 130 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.86400282 |
| 131 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.86049370 |
| 132 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.85861088 |
| 133 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.84835846 |
| 134 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.83203551 |
| 135 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.83149843 |
| 136 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.82861148 |
| 137 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.82526193 |
| 138 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.82491235 |
| 139 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.82202269 |
| 140 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.82116405 |
| 141 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.81605747 |
| 142 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.81038434 |
| 143 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.80579807 |
| 144 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.79516488 |
| 145 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.79408133 |
| 146 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77628683 |
| 147 | VDR_22108803_ChIP-Seq_LS180_Human | 0.76518955 |
| 148 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75162898 |
| 149 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.74810829 |
| 150 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.74677145 |
| 151 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.74156147 |
| 152 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.74095571 |
| 153 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.73715933 |
| 154 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.73260719 |
| 155 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.72945995 |
| 156 | GATA2_19941826_ChIP-Seq_K562_Human | 0.72936700 |
| 157 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.72767774 |
| 158 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.71426154 |
| 159 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.71413242 |
| 160 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.70984365 |
| 161 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.70441466 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006054_spinal_hemorrhage | 5.78917463 |
| 2 | MP0005670_abnormal_white_adipose | 4.30626046 |
| 3 | MP0000920_abnormal_myelination | 4.29651388 |
| 4 | MP0003950_abnormal_plasma_membrane | 3.93944021 |
| 5 | MP0004185_abnormal_adipocyte_glucose | 3.76289776 |
| 6 | MP0005666_abnormal_adipose_tissue | 3.56503185 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 3.47505979 |
| 8 | MP0004130_abnormal_muscle_cell | 3.28552396 |
| 9 | MP0003690_abnormal_glial_cell | 2.87987035 |
| 10 | MP0005375_adipose_tissue_phenotype | 2.83724694 |
| 11 | MP0008438_abnormal_cutaneous_collagen | 2.65251911 |
| 12 | MP0002837_dystrophic_cardiac_calcinosis | 2.62384454 |
| 13 | MP0000749_muscle_degeneration | 2.38896920 |
| 14 | MP0002089_abnormal_postnatal_growth/wei | 2.21750620 |
| 15 | MP0002254_reproductive_system_inflammat | 2.17344985 |
| 16 | MP0004147_increased_porphyrin_level | 2.16036888 |
| 17 | MP0000013_abnormal_adipose_tissue | 2.16011862 |
| 18 | MP0000003_abnormal_adipose_tissue | 2.11800739 |
| 19 | MP0002653_abnormal_ependyma_morphology | 2.05847053 |
| 20 | MP0004858_abnormal_nervous_system | 2.02164630 |
| 21 | MP0004036_abnormal_muscle_relaxation | 1.99139462 |
| 22 | MP0003329_amyloid_beta_deposits | 1.96566207 |
| 23 | MP0003136_yellow_coat_color | 1.95540851 |
| 24 | MP0005360_urolithiasis | 1.94297899 |
| 25 | MP0000751_myopathy | 1.91852754 |
| 26 | MP0002971_abnormal_brown_adipose | 1.87367347 |
| 27 | MP0001915_intracranial_hemorrhage | 1.85925879 |
| 28 | MP0001661_extended_life_span | 1.83939347 |
| 29 | MP0001529_abnormal_vocalization | 1.82773844 |
| 30 | MP0004043_abnormal_pH_regulation | 1.77254004 |
| 31 | MP0010329_abnormal_lipoprotein_level | 1.76577717 |
| 32 | MP0010386_abnormal_urinary_bladder | 1.74819019 |
| 33 | MP0005171_absent_coat_pigmentation | 1.73583653 |
| 34 | MP0000747_muscle_weakness | 1.72127481 |
| 35 | MP0004145_abnormal_muscle_electrophysio | 1.71611236 |
| 36 | MP0005451_abnormal_body_composition | 1.69747437 |
| 37 | MP0003195_calcinosis | 1.69458222 |
| 38 | MP0003879_abnormal_hair_cell | 1.65022181 |
| 39 | MP0005595_abnormal_vascular_smooth | 1.63245861 |
| 40 | MP0005646_abnormal_pituitary_gland | 1.60106208 |
| 41 | MP0003646_muscle_fatigue | 1.57184507 |
| 42 | MP0005330_cardiomyopathy | 1.56331361 |
| 43 | MP0003186_abnormal_redox_activity | 1.55720790 |
| 44 | MP0009780_abnormal_chondrocyte_physiolo | 1.53896360 |
| 45 | MP0003634_abnormal_glial_cell | 1.53548405 |
| 46 | MP0003806_abnormal_nucleotide_metabolis | 1.47866691 |
| 47 | MP0001984_abnormal_olfaction | 1.47346378 |
| 48 | MP0003724_increased_susceptibility_to | 1.43510518 |
| 49 | MP0005620_abnormal_muscle_contractility | 1.36180143 |
| 50 | MP0003635_abnormal_synaptic_transmissio | 1.34513836 |
| 51 | MP0002118_abnormal_lipid_homeostasis | 1.34098376 |
| 52 | MP0004142_abnormal_muscle_tone | 1.32962860 |
| 53 | MP0004087_abnormal_muscle_fiber | 1.28797922 |
| 54 | MP0004381_abnormal_hair_follicle | 1.28150443 |
| 55 | MP0008775_abnormal_heart_ventricle | 1.25397700 |
| 56 | MP0001905_abnormal_dopamine_level | 1.24984495 |
| 57 | MP0004270_analgesia | 1.24506566 |
| 58 | MP0000759_abnormal_skeletal_muscle | 1.23083420 |
| 59 | MP0005423_abnormal_somatic_nervous | 1.22862051 |
| 60 | MP0004742_abnormal_vestibular_system | 1.22680378 |
| 61 | MP0005275_abnormal_skin_tensile | 1.22195799 |
| 62 | MP0006036_abnormal_mitochondrial_physio | 1.21056742 |
| 63 | MP0004885_abnormal_endolymph | 1.20975143 |
| 64 | MP0009745_abnormal_behavioral_response | 1.20927132 |
| 65 | MP0005058_abnormal_lysosome_morphology | 1.20648243 |
| 66 | MP0001299_abnormal_eye_distance/ | 1.20183092 |
| 67 | MP0002272_abnormal_nervous_system | 1.19706691 |
| 68 | MP0004215_abnormal_myocardial_fiber | 1.18853692 |
| 69 | MP0000467_abnormal_esophagus_morphology | 1.18095473 |
| 70 | MP0002064_seizures | 1.17277631 |
| 71 | MP0005551_abnormal_eye_electrophysiolog | 1.17040078 |
| 72 | MP0002106_abnormal_muscle_physiology | 1.16980241 |
| 73 | MP0002972_abnormal_cardiac_muscle | 1.15481549 |
| 74 | MP0000613_abnormal_salivary_gland | 1.15040300 |
| 75 | MP0005334_abnormal_fat_pad | 1.14334632 |
| 76 | MP0002876_abnormal_thyroid_physiology | 1.13978484 |
| 77 | MP0001502_abnormal_circadian_rhythm | 1.11689842 |
| 78 | MP0004084_abnormal_cardiac_muscle | 1.08465976 |
| 79 | MP0002909_abnormal_adrenal_gland | 1.08342372 |
| 80 | MP0006138_congestive_heart_failure | 1.08213975 |
| 81 | MP0003656_abnormal_erythrocyte_physiolo | 1.07876960 |
| 82 | MP0008260_abnormal_autophagy | 1.07821418 |
| 83 | MP0000750_abnormal_muscle_regeneration | 1.07309060 |
| 84 | MP0005535_abnormal_body_temperature | 1.07151959 |
| 85 | MP0001486_abnormal_startle_reflex | 1.06256596 |
| 86 | MP0003137_abnormal_impulse_conducting | 1.06134251 |
| 87 | MP0005369_muscle_phenotype | 1.05628746 |
| 88 | MP0006276_abnormal_autonomic_nervous | 1.05178372 |
| 89 | MP0002638_abnormal_pupillary_reflex | 1.03791900 |
| 90 | MP0000604_amyloidosis | 1.03742964 |
| 91 | MP0002090_abnormal_vision | 1.03365386 |
| 92 | MP0001485_abnormal_pinna_reflex | 1.03293921 |
| 93 | MP0004859_abnormal_synaptic_plasticity | 1.03133636 |
| 94 | MP0010678_abnormal_skin_adnexa | 0.99829762 |
| 95 | MP0009115_abnormal_fat_cell | 0.99187636 |
| 96 | MP0003959_abnormal_lean_body | 0.97437366 |
| 97 | MP0004085_abnormal_heartbeat | 0.97007615 |
| 98 | MP0003633_abnormal_nervous_system | 0.96588264 |
| 99 | MP0002229_neurodegeneration | 0.95731915 |
| 100 | MP0003828_pulmonary_edema | 0.93716590 |
| 101 | MP0002796_impaired_skin_barrier | 0.93013205 |
| 102 | MP0003880_abnormal_central_pattern | 0.92324420 |
| 103 | MP0005410_abnormal_fertilization | 0.91415894 |
| 104 | MP0001944_abnormal_pancreas_morphology | 0.91290835 |
| 105 | MP0001348_abnormal_lacrimal_gland | 0.90536566 |
| 106 | MP0005409_darkened_coat_color | 0.90236160 |
| 107 | MP0003191_abnormal_cellular_cholesterol | 0.90045129 |
| 108 | MP0000647_abnormal_sebaceous_gland | 0.89923187 |
| 109 | MP0004134_abnormal_chest_morphology | 0.89243649 |
| 110 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.88972607 |
| 111 | MP0002295_abnormal_pulmonary_circulatio | 0.88653204 |
| 112 | MP0001440_abnormal_grooming_behavior | 0.88161715 |
| 113 | MP0000343_altered_response_to | 0.87554540 |
| 114 | MP0008569_lethality_at_weaning | 0.87169603 |
| 115 | MP0002139_abnormal_hepatobiliary_system | 0.86503578 |
| 116 | MP0005645_abnormal_hypothalamus_physiol | 0.86346398 |
| 117 | MP0005448_abnormal_energy_balance | 0.86318768 |
| 118 | MP0002078_abnormal_glucose_homeostasis | 0.86227232 |
| 119 | MP0003631_nervous_system_phenotype | 0.85919495 |
| 120 | MP0005452_abnormal_adipose_tissue | 0.85489278 |
| 121 | MP0004019_abnormal_vitamin_homeostasis | 0.84375546 |
| 122 | MP0005385_cardiovascular_system_phenoty | 0.83206091 |
| 123 | MP0001544_abnormal_cardiovascular_syste | 0.83206091 |
| 124 | MP0000383_abnormal_hair_follicle | 0.82925874 |
| 125 | MP0003283_abnormal_digestive_organ | 0.81668484 |
| 126 | MP0003221_abnormal_cardiomyocyte_apopto | 0.80898097 |
| 127 | MP0002693_abnormal_pancreas_physiology | 0.80267835 |
| 128 | MP0003868_abnormal_feces_composition | 0.79991164 |
| 129 | MP0005085_abnormal_gallbladder_physiolo | 0.79795826 |
| 130 | MP0001851_eye_inflammation | 0.79173570 |
| 131 | MP0002734_abnormal_mechanical_nocicepti | 0.78003695 |
| 132 | MP0004272_abnormal_basement_membrane | 0.77812383 |
| 133 | MP0002332_abnormal_exercise_endurance | 0.77213122 |
| 134 | MP0003632_abnormal_nervous_system | 0.76606988 |
| 135 | MP0001727_abnormal_embryo_implantation | 0.76318903 |
| 136 | MP0005332_abnormal_amino_acid | 0.76082362 |
| 137 | MP0002108_abnormal_muscle_morphology | 0.75906146 |
| 138 | MP0002063_abnormal_learning/memory/cond | 0.75816521 |
| 139 | MP0005379_endocrine/exocrine_gland_phen | 0.74383342 |
| 140 | MP0005388_respiratory_system_phenotype | 0.72437194 |
| 141 | MP0002133_abnormal_respiratory_system | 0.72437194 |
| 142 | MP0002822_catalepsy | 0.72412010 |
| 143 | MP0001756_abnormal_urination | 0.71880479 |
| 144 | MP0004484_altered_response_of | 0.71348694 |
| 145 | MP0006082_CNS_inflammation | 0.70482636 |
| 146 | MP0003011_delayed_dark_adaptation | 0.69658540 |
| 147 | MP0000230_abnormal_systemic_arterial | 0.68627855 |
| 148 | MP0001501_abnormal_sleep_pattern | 0.67656492 |
| 149 | MP0009643_abnormal_urine_homeostasis | 0.66971034 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Disinhibition (HP:0000734) | 8.70618009 |
| 2 | Progressive external ophthalmoplegia (HP:0000590) | 6.76112389 |
| 3 | Upper motor neuron abnormality (HP:0002127) | 6.37240772 |
| 4 | Inappropriate behavior (HP:0000719) | 5.78229369 |
| 5 | Personality changes (HP:0000751) | 5.48838392 |
| 6 | Mask-like facies (HP:0000298) | 5.37783406 |
| 7 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.92570529 |
| 8 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.92570529 |
| 9 | Neurofibrillary tangles (HP:0002185) | 4.74129875 |
| 10 | Muscle fiber splitting (HP:0003555) | 4.61612127 |
| 11 | Polyphagia (HP:0002591) | 4.54124948 |
| 12 | Bone cyst (HP:0012062) | 4.20787766 |
| 13 | Difficulty running (HP:0009046) | 3.89788456 |
| 14 | Amyotrophic lateral sclerosis (HP:0007354) | 3.84626817 |
| 15 | Abnormality of the motor neurons (HP:0002450) | 3.82318265 |
| 16 | Abnormal neuron morphology (HP:0012757) | 3.82318265 |
| 17 | Hyporeflexia of lower limbs (HP:0002600) | 3.80425244 |
| 18 | Abnormal eating behavior (HP:0100738) | 3.76585242 |
| 19 | Onion bulb formation (HP:0003383) | 3.51227331 |
| 20 | Parakeratosis (HP:0001036) | 3.49486835 |
| 21 | Abnormality of glycolysis (HP:0004366) | 3.48236149 |
| 22 | Increased serum pyruvate (HP:0003542) | 3.48236149 |
| 23 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.46984884 |
| 24 | Acute necrotizing encephalopathy (HP:0006965) | 3.42826324 |
| 25 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.39643981 |
| 26 | Peripheral hypomyelination (HP:0007182) | 3.38127949 |
| 27 | Diminished motivation (HP:0000745) | 3.38113813 |
| 28 | Leukodystrophy (HP:0002415) | 3.30386595 |
| 29 | Exercise-induced myalgia (HP:0003738) | 3.28073530 |
| 30 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.22235148 |
| 31 | Spastic tetraparesis (HP:0001285) | 3.20441756 |
| 32 | Basal ganglia calcification (HP:0002135) | 3.20303550 |
| 33 | Acute encephalopathy (HP:0006846) | 3.18744026 |
| 34 | External ophthalmoplegia (HP:0000544) | 3.15362147 |
| 35 | Cerebral inclusion bodies (HP:0100314) | 3.13862999 |
| 36 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.12383297 |
| 37 | Syncope (HP:0001279) | 3.10830540 |
| 38 | Abnormality of the corticospinal tract (HP:0002492) | 3.09454005 |
| 39 | Calf muscle hypertrophy (HP:0008981) | 3.07831059 |
| 40 | Pathologic fracture (HP:0002756) | 3.04068241 |
| 41 | Sensory axonal neuropathy (HP:0003390) | 2.91250550 |
| 42 | Hypoglycemic coma (HP:0001325) | 2.90969192 |
| 43 | Methylmalonic acidemia (HP:0002912) | 2.88164260 |
| 44 | Hepatic necrosis (HP:0002605) | 2.86805821 |
| 45 | Progressive macrocephaly (HP:0004481) | 2.83292054 |
| 46 | Multiple enchondromatosis (HP:0005701) | 2.83055031 |
| 47 | Stridor (HP:0010307) | 2.80735361 |
| 48 | Acanthosis nigricans (HP:0000956) | 2.80275288 |
| 49 | Lower limb hyperreflexia (HP:0002395) | 2.79185071 |
| 50 | Trismus (HP:0000211) | 2.76347544 |
| 51 | Hepatocellular necrosis (HP:0001404) | 2.76107788 |
| 52 | Axonal loss (HP:0003447) | 2.75359533 |
| 53 | Oligomenorrhea (HP:0000876) | 2.75333966 |
| 54 | Apathy (HP:0000741) | 2.70703088 |
| 55 | Muscle fiber inclusion bodies (HP:0100299) | 2.70237387 |
| 56 | Gowers sign (HP:0003391) | 2.69405760 |
| 57 | Nemaline bodies (HP:0003798) | 2.67646609 |
| 58 | Mitochondrial inheritance (HP:0001427) | 2.67123341 |
| 59 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.66806903 |
| 60 | Myoglobinuria (HP:0002913) | 2.66124553 |
| 61 | Abnormal auditory evoked potentials (HP:0006958) | 2.62872730 |
| 62 | Hepatosplenomegaly (HP:0001433) | 2.62391681 |
| 63 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.62249369 |
| 64 | Increased muscle lipid content (HP:0009058) | 2.60028208 |
| 65 | Choanal stenosis (HP:0000452) | 2.57723800 |
| 66 | Hypoplasia of the uterus (HP:0000013) | 2.56694555 |
| 67 | Neck muscle weakness (HP:0000467) | 2.54054800 |
| 68 | Cortical dysplasia (HP:0002539) | 2.53977818 |
| 69 | Termporal pattern (HP:0011008) | 2.53900441 |
| 70 | Insidious onset (HP:0003587) | 2.53900441 |
| 71 | Myokymia (HP:0002411) | 2.53100747 |
| 72 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.48894198 |
| 73 | Cerebral hypomyelination (HP:0006808) | 2.48086549 |
| 74 | Foot dorsiflexor weakness (HP:0009027) | 2.47097980 |
| 75 | Cerebral hemorrhage (HP:0001342) | 2.45705219 |
| 76 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.42557594 |
| 77 | Abnormality of glycine metabolism (HP:0010895) | 2.42557594 |
| 78 | Pheochromocytoma (HP:0002666) | 2.39978501 |
| 79 | Intention tremor (HP:0002080) | 2.32615022 |
| 80 | Generalized aminoaciduria (HP:0002909) | 2.31093694 |
| 81 | Muscle stiffness (HP:0003552) | 2.29348422 |
| 82 | Hypoplasia of the iris (HP:0007676) | 2.28600103 |
| 83 | Respiratory failure (HP:0002878) | 2.27894386 |
| 84 | Unilateral renal agenesis (HP:0000122) | 2.26466082 |
| 85 | Abnormality of the foot musculature (HP:0001436) | 2.26112235 |
| 86 | EMG: myopathic abnormalities (HP:0003458) | 2.24653481 |
| 87 | Dicarboxylic aciduria (HP:0003215) | 2.24049724 |
| 88 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.24049724 |
| 89 | Premature skin wrinkling (HP:0100678) | 2.23276284 |
| 90 | Renal Fanconi syndrome (HP:0001994) | 2.23023831 |
| 91 | Cerebral edema (HP:0002181) | 2.22321502 |
| 92 | Slow saccadic eye movements (HP:0000514) | 2.22019378 |
| 93 | Supranuclear gaze palsy (HP:0000605) | 2.20647218 |
| 94 | Increased CSF lactate (HP:0002490) | 2.18983381 |
| 95 | Exercise-induced muscle cramps (HP:0003710) | 2.18696874 |
| 96 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.17930722 |
| 97 | Neuroendocrine neoplasm (HP:0100634) | 2.16327550 |
| 98 | Methylmalonic aciduria (HP:0012120) | 2.13539482 |
| 99 | Increased variability in muscle fiber diameter (HP:0003557) | 2.12224500 |
| 100 | Clumsiness (HP:0002312) | 2.11460603 |
| 101 | Gliosis (HP:0002171) | 2.10950583 |
| 102 | Rhabdomyolysis (HP:0003201) | 2.10063839 |
| 103 | Type 1 muscle fiber predominance (HP:0003803) | 2.08297491 |
| 104 | Spastic paraparesis (HP:0002313) | 2.07166606 |
| 105 | Retinal dysplasia (HP:0007973) | 2.05619451 |
| 106 | Lipoatrophy (HP:0100578) | 2.03500189 |
| 107 | Ileus (HP:0002595) | 2.03238394 |
| 108 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.02507251 |
| 109 | 3-Methylglutaconic aciduria (HP:0003535) | 2.02057436 |
| 110 | Difficulty walking (HP:0002355) | 2.00644959 |
| 111 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 13.0867834 |
| 112 | Agnosia (HP:0010524) | 12.7725855 |
| 113 | Hypertriglyceridemia (HP:0002155) | 1.99135391 |
| 114 | Alacrima (HP:0000522) | 1.97505647 |
| 115 | Memory impairment (HP:0002354) | 1.97280650 |
| 116 | Abnormality of the calf musculature (HP:0001430) | 1.96716775 |
| 117 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.95851851 |
| 118 | Spastic gait (HP:0002064) | 1.95739546 |
| 119 | Dysmetria (HP:0001310) | 1.94432516 |
| 120 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.93008647 |
| 121 | Rapidly progressive (HP:0003678) | 1.90485690 |
| 122 | Nausea (HP:0002018) | 1.90210675 |
| 123 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.90204064 |
| 124 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.90204064 |
| 125 | Dilated cardiomyopathy (HP:0001644) | 1.89807457 |
| 126 | Infantile muscular hypotonia (HP:0008947) | 1.89610234 |
| 127 | Lipid accumulation in hepatocytes (HP:0006561) | 1.88941635 |
| 128 | Paraparesis (HP:0002385) | 1.88124606 |
| 129 | Paralysis (HP:0003470) | 1.86692664 |
| 130 | Hyperlipoproteinemia (HP:0010980) | 1.86245960 |
| 131 | Round ear (HP:0100830) | 1.85975675 |
| 132 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.83616211 |
| 133 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.83103690 |
| 134 | Exercise intolerance (HP:0003546) | 1.82984870 |
| 135 | Hyperglycinuria (HP:0003108) | 1.82805751 |
| 136 | Metabolic alkalosis (HP:0200114) | 1.79984965 |
| 137 | Ankle clonus (HP:0011448) | 1.79822042 |
| 138 | Polar cataract (HP:0010696) | 1.79684494 |
| 139 | Large for gestational age (HP:0001520) | 1.78864150 |
| 140 | Scanning speech (HP:0002168) | 1.78768886 |
| 141 | Increased intramyocellular lipid droplets (HP:0012240) | 1.78255253 |
| 142 | Dementia (HP:0000726) | 1.77569833 |
| 143 | Aqueductal stenosis (HP:0002410) | 1.76368748 |
| 144 | Abnormality of the basal ganglia (HP:0002134) | 1.75464950 |
| 145 | Peripheral demyelination (HP:0011096) | 1.74591094 |
| 146 | Proximal tubulopathy (HP:0000114) | 1.73259810 |
| 147 | Dysphagia (HP:0002015) | 1.63193146 |
| 148 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.62206151 |
| 149 | Hypophosphatemic rickets (HP:0004912) | 1.60409368 |
| 150 | Myoclonus (HP:0001336) | 1.59976849 |
| 151 | Abnormal cartilage morphology (HP:0002763) | 1.59873256 |
| 152 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.59281888 |
| 153 | Recurrent bacterial skin infections (HP:0005406) | 1.58959963 |
| 154 | Increased IgM level (HP:0003496) | 1.58344462 |
| 155 | Decreased circulating renin level (HP:0003351) | 1.57532640 |
| 156 | Congenital, generalized hypertrichosis (HP:0004540) | 1.57117640 |
| 157 | Oculomotor apraxia (HP:0000657) | 1.52309863 |
| 158 | Insulin resistance (HP:0000855) | 1.49423674 |
| 159 | Acute hepatic failure (HP:0006554) | 1.47884988 |
| 160 | Distal lower limb muscle weakness (HP:0009053) | 1.46565729 |
| 161 | Irritability (HP:0000737) | 1.38874253 |
| 162 | Short hallux (HP:0010109) | 1.38221601 |
| 163 | Turricephaly (HP:0000262) | 1.37936833 |
| 164 | Tetraplegia (HP:0002445) | 1.36354976 |
| 165 | Fetal akinesia sequence (HP:0001989) | 1.35123420 |
| 166 | Neuronal loss in central nervous system (HP:0002529) | 1.34435838 |
| 167 | Absent thumb (HP:0009777) | 1.34228497 |
| 168 | Renal cortical cysts (HP:0000803) | 1.34184450 |
| 169 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.34140633 |
| 170 | Myotonia (HP:0002486) | 1.31207877 |
| 171 | Increased circulating renin level (HP:0000848) | 1.30385046 |
| 172 | Facial cleft (HP:0002006) | 1.28755430 |
| 173 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.28204884 |
| 174 | Abnormality of renin-angiotensin system (HP:0000847) | 1.27956000 |
| 175 | Hemiplegia (HP:0002301) | 1.27788836 |
| 176 | Annular pancreas (HP:0001734) | 1.27627041 |
| 177 | Short chin (HP:0000331) | 1.26499806 |
| 178 | Urinary incontinence (HP:0000020) | 1.25698827 |
| 179 | Coronal craniosynostosis (HP:0004440) | 1.25155348 |
| 180 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.21360229 |
| 181 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.21251226 |
| 182 | Bone pain (HP:0002653) | 1.18837192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCYL2 | 6.73914511 |
| 2 | EIF2AK1 | 6.43903475 |
| 3 | STK39 | 5.83411890 |
| 4 | EPHB1 | 3.67917583 |
| 5 | OXSR1 | 3.39184138 |
| 6 | EEF2K | 3.28180914 |
| 7 | MAPKAPK5 | 3.19742137 |
| 8 | MAPKAPK3 | 2.82131550 |
| 9 | PKN1 | 2.77944399 |
| 10 | WNK4 | 2.47456716 |
| 11 | PBK | 2.45534036 |
| 12 | BCKDK | 2.23081525 |
| 13 | PHKG2 | 2.21310925 |
| 14 | PHKG1 | 2.21310925 |
| 15 | OBSCN | 2.16963609 |
| 16 | MET | 2.08111573 |
| 17 | BCR | 1.96250781 |
| 18 | CAMK1D | 1.93603391 |
| 19 | FGFR2 | 1.84797505 |
| 20 | WNK1 | 1.80565390 |
| 21 | RPS6KB2 | 1.69936665 |
| 22 | MUSK | 1.66700407 |
| 23 | DYRK1A | 1.66218186 |
| 24 | LIMK1 | 1.59610915 |
| 25 | TESK1 | 1.59453014 |
| 26 | MAP2K6 | 1.56910890 |
| 27 | PTK2B | 1.56253869 |
| 28 | CAMK1G | 1.56145892 |
| 29 | CDK19 | 1.55684888 |
| 30 | FGFR1 | 1.51017401 |
| 31 | MST4 | 1.48075997 |
| 32 | MAP3K4 | 1.47784972 |
| 33 | MAP3K1 | 1.46437649 |
| 34 | LMTK2 | 1.39060982 |
| 35 | EPHA2 | 1.38443733 |
| 36 | TESK2 | 1.31990829 |
| 37 | PIK3CA | 1.31427818 |
| 38 | CAMK2D | 1.28059250 |
| 39 | ROCK2 | 1.22088899 |
| 40 | PRKD1 | 1.20465836 |
| 41 | NEK2 | 1.19669216 |
| 42 | TTN | 1.19166240 |
| 43 | TRPM7 | 1.18552296 |
| 44 | CSNK1G3 | 1.18405266 |
| 45 | CAMK2B | 1.18064717 |
| 46 | CSNK1A1L | 1.13018376 |
| 47 | NTRK3 | 1.11973172 |
| 48 | CLK1 | 1.08102989 |
| 49 | SGK494 | 1.07262542 |
| 50 | SGK223 | 1.07262542 |
| 51 | MARK1 | 1.05492938 |
| 52 | CSNK1G1 | 1.05008181 |
| 53 | MAPK15 | 1.04984210 |
| 54 | GRK5 | 1.03659223 |
| 55 | FRK | 1.00940295 |
| 56 | CAMK2G | 0.99611575 |
| 57 | BMPR1B | 0.98171133 |
| 58 | PINK1 | 0.96210967 |
| 59 | PDK2 | 0.92530039 |
| 60 | SIK1 | 0.91614280 |
| 61 | PDK3 | 0.91369082 |
| 62 | PDK4 | 0.91369082 |
| 63 | EPHA4 | 0.91165648 |
| 64 | PDPK1 | 0.90264845 |
| 65 | DYRK2 | 0.89331710 |
| 66 | PRKAA2 | 0.88614497 |
| 67 | DAPK2 | 0.87786226 |
| 68 | EPHA3 | 0.87038839 |
| 69 | NEK6 | 0.86895711 |
| 70 | RPS6KA5 | 0.85566454 |
| 71 | DMPK | 0.84610681 |
| 72 | TIE1 | 0.83703944 |
| 73 | PRKCQ | 0.82812653 |
| 74 | UHMK1 | 0.81695681 |
| 75 | MAP4K2 | 0.78502994 |
| 76 | MAP3K9 | 0.78404115 |
| 77 | CDK15 | 0.77138314 |
| 78 | GRK1 | 0.76000102 |
| 79 | GRK7 | 0.75479562 |
| 80 | LATS2 | 0.74801365 |
| 81 | NME2 | 0.73987800 |
| 82 | CDK18 | 0.72327885 |
| 83 | CDK11A | 0.72221043 |
| 84 | NEK9 | 0.72206832 |
| 85 | MAP2K2 | 0.71629985 |
| 86 | FGR | 0.71496687 |
| 87 | MARK2 | 0.71280638 |
| 88 | MAPK7 | 0.70579604 |
| 89 | NTRK1 | 0.68516613 |
| 90 | ILK | 0.68330666 |
| 91 | IRAK2 | 0.67896365 |
| 92 | PIK3CG | 0.67618270 |
| 93 | CSNK1G2 | 0.67567816 |
| 94 | MYLK | 0.66009212 |
| 95 | PRKCE | 0.65826762 |
| 96 | FER | 0.65798374 |
| 97 | DAPK3 | 0.64193308 |
| 98 | GSK3A | 0.62303060 |
| 99 | SYK | 0.61703838 |
| 100 | CDK14 | 0.58733340 |
| 101 | INSRR | 0.57266878 |
| 102 | PAK3 | 0.56492957 |
| 103 | ARAF | 0.56351951 |
| 104 | PRKCZ | 0.55881704 |
| 105 | MAPK13 | 0.55875954 |
| 106 | TNIK | 0.55860908 |
| 107 | CAMK2A | 0.54378339 |
| 108 | PRKD2 | 0.53791905 |
| 109 | MAPK12 | 0.53077257 |
| 110 | EPHB2 | 0.52693997 |
| 111 | PDK1 | 0.52266968 |
| 112 | PKN2 | 0.52190716 |
| 113 | PRKD3 | 0.51872644 |
| 114 | PRKCH | 0.51194248 |
| 115 | PRKG1 | 0.50323066 |
| 116 | IRAK1 | 0.50191021 |
| 117 | CSNK1D | 0.49145256 |
| 118 | NME1 | 0.47707151 |
| 119 | BLK | 0.46349579 |
| 120 | RIPK1 | 0.46098962 |
| 121 | MST1R | 0.46041418 |
| 122 | IGF1R | 0.45015650 |
| 123 | KSR2 | 0.44546511 |
| 124 | PRKACG | 0.43993664 |
| 125 | PRKCA | 0.42635930 |
| 126 | PRKACB | 0.40617303 |
| 127 | TLK1 | 0.39734930 |
| 128 | PRKAA1 | 0.38955770 |
| 129 | FLT3 | 0.38739780 |
| 130 | STK16 | 0.37847740 |
| 131 | CDK5 | 0.37775058 |
| 132 | PRKCG | 0.36674913 |
| 133 | TYRO3 | 0.36579778 |
| 134 | TEC | 0.36248185 |
| 135 | CAMK1 | 0.36172327 |
| 136 | PRKACA | 0.35619770 |
| 137 | ADRBK2 | 0.35488310 |
| 138 | NTRK2 | 0.35165781 |
| 139 | PRKG2 | 0.33961763 |
| 140 | FYN | 0.33264403 |
| 141 | ITK | 0.33210412 |
| 142 | ICK | 0.32687401 |
| 143 | MOS | 0.32568397 |
| 144 | PTK2 | 0.32565980 |
| 145 | DDR2 | 0.32258481 |
| 146 | JAK1 | 0.31583062 |
| 147 | HIPK2 | 0.30617158 |
| 148 | PAK6 | 0.30414739 |
| 149 | INSR | 0.30396867 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur relay system_Homo sapiens_hsa04122 | 5.53638252 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.81445594 |
| 3 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.25808344 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.39840940 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.90490016 |
| 6 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.89125392 |
| 7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.82337784 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.76076077 |
| 9 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.49657522 |
| 10 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 2.48297434 |
| 11 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.44329427 |
| 12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.42246858 |
| 13 | Parkinsons disease_Homo sapiens_hsa05012 | 2.39561047 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.34850207 |
| 15 | * Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.32102039 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.22626542 |
| 17 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.19375232 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.09724777 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.06535239 |
| 20 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.01423742 |
| 21 | Alzheimers disease_Homo sapiens_hsa05010 | 2.00076337 |
| 22 | * Ether lipid metabolism_Homo sapiens_hsa00565 | 1.83702568 |
| 23 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.77668138 |
| 24 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.66568069 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.61628157 |
| 26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.54877511 |
| 27 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.53615228 |
| 28 | Circadian rhythm_Homo sapiens_hsa04710 | 1.53169854 |
| 29 | Protein export_Homo sapiens_hsa03060 | 1.53098902 |
| 30 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.51955254 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.48949034 |
| 32 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.43491049 |
| 33 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.42596603 |
| 34 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.42507726 |
| 35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.40056591 |
| 36 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.39901261 |
| 37 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.37079310 |
| 38 | Peroxisome_Homo sapiens_hsa04146 | 1.34438299 |
| 39 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.33528663 |
| 40 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.30878914 |
| 41 | Huntingtons disease_Homo sapiens_hsa05016 | 1.26055163 |
| 42 | Nicotine addiction_Homo sapiens_hsa05033 | 1.17515529 |
| 43 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.16447475 |
| 44 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.15524521 |
| 45 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.13975890 |
| 46 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.10378019 |
| 47 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.05722720 |
| 48 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.05352417 |
| 49 | Phototransduction_Homo sapiens_hsa04744 | 1.04334092 |
| 50 | Insulin secretion_Homo sapiens_hsa04911 | 1.03645834 |
| 51 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.98329289 |
| 52 | Bile secretion_Homo sapiens_hsa04976 | 0.97163767 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96947367 |
| 54 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.94722293 |
| 55 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.94098029 |
| 56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.93593492 |
| 57 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.90187447 |
| 58 | RNA polymerase_Homo sapiens_hsa03020 | 0.86581078 |
| 59 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.86442151 |
| 60 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.84466440 |
| 61 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.83866483 |
| 62 | Carbon metabolism_Homo sapiens_hsa01200 | 0.80607694 |
| 63 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.79612626 |
| 64 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.78030641 |
| 65 | * Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.76904502 |
| 66 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.76429361 |
| 67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.74864256 |
| 68 | * alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.74841496 |
| 69 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.73650537 |
| 70 | Cocaine addiction_Homo sapiens_hsa05030 | 0.73468601 |
| 71 | Morphine addiction_Homo sapiens_hsa05032 | 0.72242748 |
| 72 | * Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.70798836 |
| 73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69629149 |
| 74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.68506497 |
| 75 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.67994756 |
| 76 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.67806932 |
| 77 | * Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.65694079 |
| 78 | Tight junction_Homo sapiens_hsa04530 | 0.65350456 |
| 79 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.64754079 |
| 80 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.62204986 |
| 81 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.61516138 |
| 82 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60221169 |
| 83 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.58528188 |
| 84 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.58105728 |
| 85 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57624520 |
| 86 | Circadian entrainment_Homo sapiens_hsa04713 | 0.57449459 |
| 87 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.55107251 |
| 88 | Long-term potentiation_Homo sapiens_hsa04720 | 0.53561103 |
| 89 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.53488104 |
| 90 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.53473645 |
| 91 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.51555189 |
| 92 | Lysosome_Homo sapiens_hsa04142 | 0.51349534 |
| 93 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.50497135 |
| 94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49354948 |
| 95 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.48221259 |
| 96 | Gap junction_Homo sapiens_hsa04540 | 0.45839597 |
| 97 | Malaria_Homo sapiens_hsa05144 | 0.45814330 |
| 98 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.45598275 |
| 99 | Melanoma_Homo sapiens_hsa05218 | 0.45312715 |
| 100 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.44735947 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.44661521 |
| 102 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43339791 |
| 103 | Ribosome_Homo sapiens_hsa03010 | 0.40080436 |
| 104 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39767078 |
| 105 | ABC transporters_Homo sapiens_hsa02010 | 0.39669570 |
| 106 | Taste transduction_Homo sapiens_hsa04742 | 0.39472153 |
| 107 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37825950 |
| 108 | Renin secretion_Homo sapiens_hsa04924 | 0.36985689 |
| 109 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.35143681 |
| 110 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.32972487 |
| 111 | Axon guidance_Homo sapiens_hsa04360 | 0.32934557 |
| 112 | Allograft rejection_Homo sapiens_hsa05330 | 0.32914869 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | 0.32054607 |
| 114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.30002631 |
| 115 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.28975928 |
| 116 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.28169720 |
| 117 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.27610357 |
| 118 | Endocytosis_Homo sapiens_hsa04144 | 0.27035921 |
| 119 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.26743677 |
| 120 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.23379767 |
| 121 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.21648456 |
| 122 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.21505927 |
| 123 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.20921178 |
| 124 | Retinol metabolism_Homo sapiens_hsa00830 | 0.19922697 |
| 125 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.19663742 |
| 126 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.18878131 |
| 127 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.17957745 |
| 128 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.17534244 |
| 129 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.17384277 |
| 130 | Salivary secretion_Homo sapiens_hsa04970 | 0.16241299 |
| 131 | Viral myocarditis_Homo sapiens_hsa05416 | 0.14838878 |
| 132 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.13730579 |
| 133 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.12736146 |
| 134 | Asthma_Homo sapiens_hsa05310 | 0.11827697 |
| 135 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.11201122 |
| 136 | GABAergic synapse_Homo sapiens_hsa04727 | 0.11138190 |
| 137 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.11027370 |
| 138 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.10180342 |
| 139 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.09650214 |

